🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Medikabazaar appoints Dinesh Lodha as group CEO

EntrackrEntrackr · 10m ago
Medikabazaar appoints Dinesh Lodha as group CEO
Medial

B2B medical supply chain platform Medikabazaar has appointed Dinesh Lodha as its new Group chief executive officer (CEO). With over two decades of experience in the medtech industry and a career marked by leadership roles across various sectors, Lodha brings a wealth of expertise to Medikabazaar. Before joining Medikabazaar, Lodha managed large B2B and B2C operations in FMCG and healthcare sectors. He has worked with multinational, private equity-led businesses and large publicly listed Indian companies. Founded by Vivek Tiwari and Ketan Malkan, nine-year-old Medikabazaar enables hospitals and medical establishments to discover supplies, compare specifications and prices in real-time. The product on the B2B platform includes hospital devices, materials, medical consumables, and dental tools among others. The platform offers over 4 lakh products and serves over 10,000 medical centres and over 30,000 independent doctors and clinics. It has a B2B marketplace, an AI-ML-powered SaaS solution, a medical financing solution, full stack procurement model for large hospitals, and an asset management platform for equipment business. In April 2022, Medikabazaar had scooped up $65 in a new funding round led by Lighthouse India Fund III and others at a valuation of $700 million. According to data intelligence platform, The Kredible, the operating gross revenue for the Mumbai-based company grew 2.74X to Rs 1,552.53 crore in FY22 from Rs 564.7 crore in FY21.

Medikabazaar ousts former CEO Vivek Tiwari over fraud allegations

EntrackrEntrackr · 2m ago
Medikabazaar ousts former CEO Vivek Tiwari over fraud allegations
Medial

Medikabazaar ousts former CEO Vivek Tiwari over fraud allegations B2B medical supply chain platform Medikabazaar has removed its director and former CEO, Vivek Tiwari, from the company over allegations of malicious and fraudulent activities. The shareholders of the company have passed a resolution to remove Tiwari from the board of directors for doing fraudulent actions, according to its regulatory filing accessed from the Registrar of Companies (RoC). “Mr. Vivek Tiwari is involved in malicious and fraudulent activities, including those of financial mismanagement and financial fraud, which have caused irreparable harm and damage, and are alarming to the well-being of the company”, the filing stated. Uniqus India, Alvarez & Marsal, and M/s Rashmikant & Partners conducted the investigation and concluded that he had breached fiduciary duty and was guilty of gross negligence, misappropriation, and misstatements, the filing further stated. According to PwC auditors, inconsistencies in revenue recognition and multiple governance issues led to the removal of Vivek Tiwari from his role as Chief Executive Officer of the company last year. Medikabazaar has secured over $190 million in total funding across multiple rounds. This includes a $65 million Series D round in 2022, led by Lighthouse India, which valued the company at $700 million. According to startup data intelligence platform TheKredible, Craegis holds the largest external stake in the company, followed by Rebright Partners and HealthQuad. Co-founders Vivek Tiwari and Ketan Malkan own 12.36% and 12.35% of the company, respectively. Medikabazaar has not yet filed its annual report for the fiscal year ending March 2024. In FY23, the company reported revenue of Rs 908 crore and a net loss of Rs 304 crore. Notably, its Series C investors have raised an indemnity claim of Rs 278.7 crore, alleging misreporting in prior financial periods.

Download the medial app to read full posts, comements and news.